Compare Novavax Inc (NVAX) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs D Wave Quantum Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while D Wave Quantum Inc trades at $17.9 (market cap $6.19B). The key difference: D Wave Quantum Inc is far larger — about 4.8× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | QBTS | |
|---|---|---|
Market Cap | $1.30B | $6.19B |
Sector | Health | Technology |
52-Week High | $11.19 | $44.78 |
52-Week Low | $6.22 | $12.98 |
Enterprise Value | $800.50M | $5.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
